Picture of Vivesto AB logo

VIVE Vivesto AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Vivesto Reports Positive Interim Results For Paccal Vet Pilot Study In Dogs

Nov 7 (Reuters) - Vivesto AB VIVE.ST:

REPORTS POSITIVE INTERIM RESULTS FOR PACCAL VET PILOT STUDY IN DOGS

PACAL VET TREATMENT EXTENDS SURVIVAL IN DOGS WITH HEMANGIOSARCOMA

PIVOTAL STUDY PLANNED IF POSITIVE RESULTS CONFIRMED

Source text: ID:nMFN6ZsyHP

Further company coverage: VIVE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Vivesto AB

See all news